| Literature DB >> 31738865 |
Brynley Hull1, Alexandra Hendry1, Aditi Dey1, Julia Brotherton2, Kristine Macartney1, Frank Beard1.
Abstract
This eleventh national annual immunisation coverage report focuses on data for the calendar year 2017 derived from the Australian Immunisation Register (AIR) and the National Human Papillomavirus (HPV) Vaccination Program Register. This is the first report to include data on HPV vaccine course completion in Aboriginal and Torres Strait Islander (Indigenous) adolescents. 'Fully immunised' vaccination coverage in 2017 increased at the 12-month assessment age reaching 93.8% in December 2017, and at the 60-month assessment age reaching 94.5%. 'Fully immunised' coverage at the 24-month assessment age decreased slightly to 89.8% in December 2017, following amendment in December 2016 to require the fourth DTPa vaccine dose at 18 months. 'Fully immunised' coverage at 12 and 60 months of age in Indigenous children reached the highest ever recorded levels of 93.2% and 96.9% in December 2017. Catch-up vaccination activity for the second dose of measles-mumps-rubella-containing vaccine was considerably higher in 2017 for Indigenous compared to non-Indigenous adolescents aged 10-19 years (20.3% vs. 6.4%, respectively, of those who had not previously received that dose). In 2017, 80.2% of females and 75.9% of males aged 15 years had received a full course of three doses of human papillomavirus (HPV) vaccine. Of those who received dose one, 79% and 77% respectively of Indigenous girls and boys aged 15 years in 2017 completed three doses, compared to 91% and 90% of non-Indigenous girls and boys, respectively. A separate future report is planned to present adult AIR data and to assess completeness of reporting. © Commonwealth of Australia CC BY-NC-ND.Entities:
Keywords: zzm321990 Indigenous immunisation coveragezzm321990 ; zzm321990 adolescent immunisation coveragezzm321990 ; zzm321990 human papillomavirus vaccine coveragezzm321990 ; zzm321990 immunisation coveragezzm321990 ; zzm321990 immunisation delayzzm321990 ; zzm321990 influenza vaccinationzzm321990
Mesh:
Substances:
Year: 2019 PMID: 31738865 DOI: 10.33321/cdi.2019.43.47
Source DB: PubMed Journal: Commun Dis Intell (2018) ISSN: 2209-6051